Skip to main content
Log in

Tizanidine — Initial pharmacokinetic studies in patients with spasticity

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The time-course of plasma concentrations of the antispasticity agent tizanidine were measured by a specific radioimmune-assay in six adults who had severe spasticity due to multiple sclerosis. The drug was given as a single oral 4 mg dose to each subject. The drug had a mean absorption half-life of 0.30±0.155 h following a mean lagtime of 0.361±0.118 h, and a mean terminal elimination half-life of 4.16±2.06 h. Only 2.65±0.82% of the dose was excreted unchanged in urine in 2 h. Calculated values of clearance and apparent volume of distribution were almost certainly overestimates as it seems probable that the orally-administered drug undergoes significant presystemic elimination (its bioavailability was not determined in the investigation here reported).

Relief of spasticity, from the dosage used, was relatively slight and appeared greatest at the time of peak plasma levels of the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Brown RD, Manno JE (1978) ESTRIP, a basic computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691

    Google Scholar 

  • Degan PH, Riess W (1976) The determination of γ-amino-β-(p-chloro-phenyl)butyric acid (baclofen) in biological materials by gas-liquid chromatography. J Chromatogr 117: 399–405

    Google Scholar 

  • Hassan N, McLennan DL (1980) Double-blind comparison of DS 103–282, baclofen and placebo for suppression of spasticity. J Neurol Neurosurg Psychiatry 43: 1133–1136

    Google Scholar 

  • Horowitz DL, Homer LD (1970) Analysis of biomedical data by time-sharing computers. I. Non-linear regression analysis. Project No. MR005, 20-0287. Naval Medical Research Institute, National Naval Medical Centre, Bethesda, Maryland, 20014, USA

    Google Scholar 

  • Landau WM (1974) Spasticity: The fable of a neurological demon and the emperor's new therapy. Arch Neurol 31: 217–219

    Google Scholar 

  • Peck CC, Barrett BB (1979) Nonlinear least-squares regression programs for microcomputers. J Pharmacokinet Biopharm 7: 537–541

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heazlewood, V., Symoniw, P., Maruff, P. et al. Tizanidine — Initial pharmacokinetic studies in patients with spasticity. Eur J Clin Pharmacol 25, 65–67 (1983). https://doi.org/10.1007/BF00544016

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00544016

Key words

Navigation